Literature DB >> 16278723

Gary L. Davis, MD: a conversation with the editor. Interview by William Clifford Roberts.

Gary L Davis.   

Abstract

Year:  2003        PMID： 16278723      PMCID： PMC1200811          DOI： 10.1080/08998280.2003.11927889

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN： 0899-8280


× No keyword cloud information.
  34 in total

1.  Genomic variation of hepatitis C virus: clues to clinical variation?

Authors:  G L Davis
Journal:  Gastroenterology       Date:  1992-07       Impact factor: 22.682

Review 2.  Current concepts in the diagnosis and management of hepatitis B surface antigen-positive chronic active hepatitis.

Authors:  G L Davis; A J Czaja
Journal:  J Clin Gastroenterol       Date:  1981-12       Impact factor: 3.062

3.  Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial.

Authors:  G L Davis; L A Balart; E R Schiff; K Lindsay; H C Bodenheimer; R P Perrillo; W Carey; I M Jacobson; J Payne; J L Dienstag
Journal:  N Engl J Med       Date:  1989-11-30       Impact factor: 91.245

Review 4.  Future options for the management of hepatitis C.

Authors:  G L Davis; D R Nelson; G R Reyes
Journal:  Semin Liver Dis       Date:  1999       Impact factor: 6.115

5.  Prognostic and therapeutic implications of extreme serum aminotransferase elevation in chronic active hepatitis.

Authors:  G L Davis; A J Czaja; A H Baggenstoss; H F Taswell
Journal:  Mayo Clin Proc       Date:  1982-05       Impact factor: 7.616

6.  Quantitative detection of hepatitis C virus RNA with a solid-phase signal amplification method: definition of optimal conditions for specimen collection and clinical application in interferon-treated patients.

Authors:  G L Davis; J Y Lau; M S Urdea; P D Neuwald; J C Wilber; K Lindsay; R P Perrillo; J Albrecht
Journal:  Hepatology       Date:  1994-06       Impact factor: 17.425

7.  Significance of serum hepatitis C virus RNA levels in chronic hepatitis C.

Authors:  J Y Lau; G L Davis; J Kniffen; K P Qian; M S Urdea; C S Chan; M Mizokami; P D Neuwald; J C Wilber
Journal:  Lancet       Date:  1993-06-12       Impact factor: 79.321

8.  Spontaneous reactivation of chronic hepatitis B virus infection.

Authors:  G L Davis; J H Hoofnagle; J G Waggoner
Journal:  Gastroenterology       Date:  1984-02       Impact factor: 22.682

9.  Detection of hepatitis C virus RNA genome in liver tissue by nonisotopic in situ hybridization.

Authors:  J Y Lau; G L Davis
Journal:  J Med Virol       Date:  1994-03       Impact factor: 2.327

10.  Distribution of hepatitis C virus genotypes determined by line probe assay in patients with chronic hepatitis C seen at tertiary referral centers in the United States. Hepatitis Interventional Therapy Group.

Authors:  J Y Lau; G L Davis; L E Prescott; G Maertens; K L Lindsay; K Qian; M Mizokami; P Simmonds
Journal:  Ann Intern Med       Date:  1996-05-15       Impact factor: 25.391
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.